Product NDC: | 0409-2285 |
Proprietary Name: | Metoprolol Tartrate |
Non Proprietary Name: | Metoprolol Tartrate |
Active Ingredient(s): | 1 mg/mL & nbsp; Metoprolol Tartrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2285 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075160 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980706 |
Package NDC: | 0409-2285-05 |
Package Description: | 3 AMPULE in 1 CARTON (0409-2285-05) > 5 mL in 1 AMPULE |
NDC Code | 0409-2285-05 |
Proprietary Name | Metoprolol Tartrate |
Package Description | 3 AMPULE in 1 CARTON (0409-2285-05) > 5 mL in 1 AMPULE |
Product NDC | 0409-2285 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoprolol Tartrate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19980706 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | METOPROLOL TARTRATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |